Table 2.

Univariate analysis of the training cohort.

Variable	β	HR (95% CI for HR)	P
Statistically non-significant factors
Gender	−0.478	0.620 (0.330–1.165)	0.137
Age	0.378	1.460 (0.909–2.346)	0.118
BMI	0.001	1.001 (0.999–1.001)	0.057
ALT	0.001	1.001 (0.999–1.001)	0.075
Hemoglobin	0.099	0.905 (0.717–1.141)	0.401
APTT	0.011	1.011 (0.984–1.038)	0.413
Triglycerides	0.017	1.016 (0.806–1.281)	0.888
Cholesterol	−0.076	0.926 (0.735–1.167)	0.518
AFP	0.043	0.957 (0.759–1.206)	0.710
Location(head and other location)	0.038	1.038 (0.814–1.324)	0.759
Statistically significant factors
Tumor size	0.396	0.673 (0.502–0.903)	0.008
NLR	0.754	2.124 (1.675–2.695)	<0.001
PLR	0.463	1.588 (1.257–2.004)	<0.001
LMR	−0.782	0.457 (0.360–0.579)	<0.001
CEA	0.500	1.650 (1.305–2.085)	<0.001
CA199	0.562	1.754 (1.390–2.215)	<0.001
γ-GT	0.001	1.000 (0.999–1.000)	0.250
TNM stage(I/II vs III/IV)	0.657	1.928 (1.468–2.532)	<0.001
Nerve invasion	0.323	1.380 (1.057–1.802)	0.017
Vascular invasion	0.409	1.505 (1.173–1.932)	0.001
Globulin	0.339	0.7125 (0.563–0.901)	<0.001
Albumin	−0.245	0.782 (0.620–0.986)	0.038
AST	0.001	1.001 (1.000–1.002)	0.024
Differentiation grade	0.104	1.109 (1.009–1.218)	0.030
PT	0.103	1.108 (1.001–1.227)	0.047